Objective. This investigation was designed to assess the relationship between flow-mediated vasodilatation (FMD) and nitroglycerin (NTG)-mediated vasodilatation (NMD) with atherosclerotic risk factors. Methods. FMD and NMD were measured in 75 subjects including 57 patients with atherosclerotic disease (AAA/ PAOD ¼ 30/27, age 72 AE 7 years) and 18 controls. Brachial response to hyperemia and NTG were measured every minute after cuff deflation and NTG administration. Results. In the 75 subjects, responses to NTG showed a sigmoid curve. Only 2 cases reached maximal diameter within 4 minutes after NTG, and 90% of the cases reached maximal diameter at 6 minutes or later (7.5 AE 2.0 minutes). In patients with atherosclerotic disease, a multiple regression analysis showed higher FMD was associated with higher NMD, and higher NMD was associated with smaller vessel size, lower systolic blood pressure, higher FMD, lower carotid maximal IMT, lower serum levels of insulin, and lower HOMA-IR. Conclusions. In subjects older than 54, NMD measured at 3 or 4 minutes after NTG administration would underestimate the NTG-dependent vasodilatation. NMD measured with the maximal responded diameter was associated with atherosclerotic risk factors, and it is therefore considered to be an important parameter in patients with atherosclerotic disease. Ó
Introduction
Both the smooth muscle and endothelium play a pivotal role in atherosclerosis. 1, 2 Endothelial dysfunction is considered to be an early event in atherosclerosis, preceding ultrasonic evidence of atherosclerotic plaque. 3 Numerous studies have documented impaired brachial ultrasound assessment of endotheliume dependent vasodilatation in the plaque-free peripheral arteries of asymptomatic children and adults at risk for atherosclerosis. 4e6 This ultrasound study includes an assessment of the vasodilatory response to nitroglycerin (NTG), which acts directly at the level of the arterial smooth muscle and produces an endotheliumindependent vasodilatation. Nitroglycerin-mediated dilatation (NMD) has been used to check the vasodilatory responsiveness of smooth muscle, but the smooth muscle function in itself has almost never been previously discussed. A few studies have recently demonstrated impaired NMD to be associated with a higher systolic blood pressure, 7 the presence of diabetes mellitus, 8 higher oxidized LDL, greater carotid IMT and familial hypercholesterolemia. 9 There have been few studies of NMD and FMD in patients with peripheral arterial occlusive disease (PAOD) and abdominal aortic aneurysm (AAA). 10e14 We examined not only the magnitude but also the time courses of the response to hyperemia and sublingual NTG.
Methods

Subjects
We studied 57 patients with atherosclerotic disease (AD) including 30 patients with AAA and 27 with PAOD. The patients with PAOD had symptoms and all patients came to our hospital for the purpose of receiving appropriate treatment. AAA was diagnosed when a localized dilation of the abdominal aorta of at least 50% or larger than an adjacent normal portion was detected by either ultrasonography or computed tomography (CT). PAOD was diagnosed by duplex scanning or CT based on an ABI < 0.90. No female subjects were included in this study, because sexual differences may confound the data analysis. The exclusion criteria were decompensated heart failure, malignant neoplasma, glaucoma, the need to receive insulin therapy, ischemic gangrene, and evidence of hepatic, renal or inflammatory disease.
The sex-matched 18 control adults included in the study had an ABI > 0.9, normal electrocardiogram, and normal ultrasonographic findings of the abdominal aorta to iliac artery.
Our institutional ethics committee approved the study, and all participants gave their written informed consent.
Data collection
All subjects were asked in detail regarding their medical history, particularly regarding cardiovascular risk factors, and any vascular events. After an overnight fast a venous sample was taken, the plasma was separated from the blood cells by centrifugation. The fasting blood sugar (FBS) was measured enzymatically (SRL, Tokyo, Japan). The serum insulin levels were determined by a 2-step enzyme immunoassay (SRL, Tokyo, Japan). The plasma total homocysteine was analyzed by high-pressure liquid chromatography (SRL, Tokyo, Japan). Plasma asymmetric dimethylarginine (ADMA) was determined using high-pressure liquid chromatography (SRL, Tokyo, Japan). The serum concentration of advanced glycation end products (AGEs) was measured with an enzyme-linked immunosorbent assay (SRL, Tokyo, Japan). The serum adiponectin level was determined by an enzymelinked immunosorbent assay (SRL, Tokyo, Japan). The serum CRP was measured with a highly sensitive (hs) assay (Dade Bhering Diagnostics, Marburg, Germany). The serum triglyceride, and total cholesterol, HDL cholesterol, and LDL cholesterol levels were all measured with commercially available kits. A homeostasis model assessment of insulin resistance (HOMA-IR) was calculated using the following formula: fasting plasma insulin (mU/ml) Â fasting glucose (mmol/L)/22.5. As previously reported, 15 HOMA-IR was validated in diabetic subjects treated with diet therapy alone and in those treated with sulfonylureas. Atherosclerotic patients were studied by Carotid ultrasound by 2 independent sonographers blinded to the subject's clinical details. In brief, bilateral longitudinal scanning was performed from the common carotid artery to the internal carotid artery.
The scan was focused on the posterior (far) wall, and performed in the optimal position. The maximal thickness of intima-media complex (maxIMT) was recorded and measured with electronic calipers.
Brachial ultrasound
After an overnight (14 hours) fast, changes in the brachial diameter as a response to reactive hyperemia and as a response to 300 mg of sublingual NTG was measured using ultrasound (Aplio SSA-700A 5e12-MHz linear array transducer, Toshiba) as previously described. 16 Vasoactive medications, such as calcium antagonists, and b-blockers, ACE-inhibitors, ARBs, and Nitrates were not administered for at least 14 hours. Caffeinated beverages and smoking were not allowed on the day of the study. Briefly, the brachial artery was scanned in longitudinal sections 2 to 10 cm above the elbow (control scan) after 15 min of rest in the supine position. The depth and gain settings were optimized to identify the anterior and posterior intimal interfaces between the lumen and vessel wall, and a baseline scan was recorded on super-VHS for an offline analysis. Hyperemia was induced by inflating and deflating a forearm blood pressure cuff and it was inflated to 50 mmHg above the systolic blood pressure for 5 minutes. The vasodilator response to hyperemia was recorded for 5 minutes after deflation. After at least 10 minutes rest, a further control scan was recorded. A single 300-mg dose of NTG was sublingually administered. After the administration, we poured some water over the tablet and looked into the mouth to see if the tablet was dissolving because in older patients dissolution may sometimes be delayed due to dentures or dryness of the mouth. 17 Thereafter, the vasodilator response to NTG was recorded for 15 minutes. NTG was omitted if the subjects either refused it, had a systolic blood pressure of <100 mm Hg, or a previous adverse reaction to nitrates.
Measurements were taken at end-diastole, coincident with the R-wave on ECG, every one minute after deflation or after the administration of NTG. The arterial diameter was analyzed for three cardiac cycles, and then these measurements were averaged. The diameter responded to reactive hyperemia and NTG was expressed as a percent change relative to the diameter immediately before cuff inflation and relative to the diameter immediately before drug administration, respectively. The same operator, who was blinded to the details of subjects' data, studied all brachial ultrasound images. In our laboratory, the intraobserver variability for repeated measurements of resting arterial diameter was 0.02 AE 0.01 mm, for FMD was 0.49 AE 0.27 (%), and for NMD was 0.44 AE 0.34 (%), respectively.
Brachial IMT was measured as previously described. 9 The same segment of the brachial artery for the analysis of vasodilator response was measured for brachial IMT. The scan was focused on the posterior wall, and 8 measurements were taken at end-diastole, coincident with the R-wave, at even intervals. The average of these measurements was used as the mean brachial IMT in the analysis.
Statistical analysis
All descriptive data were expressed as the mean AE SD. A comparison for continuous variables between the groups was made by either an Analysis of covariance (ANCOVA), the t-test or the Mann-Whitney test. Categorial variables were compared with either the c 2 test or Fisher's exact probability test. Univariate associations between the study variables were analyzed by calculating the Pearson's correlation coefficient. A multiple stepwise regression analysis was used to assess which variables were significantly related to FMD or NMD. In the regression models, we first assessed the presence of a univariate correlation between the variables and FMD or NMD. The variables were then entered into the model based on the selection criteria of P < 0.10. A P value of less than 0.05 was considered to be significant. All statistical analyses were performed using the Stat View 5.0 statistical analysis software program.
Results
All 75 subjects underwent the FMD evaluation, but 2 AD patients refused to take NTG. In the present study, the AD patients were significantly older than control subjects (72 AE 7 years, range 54 to 86 versus 69 AE 3 years, range 65 to 75, p ¼ 0.013). Therefore, a comparison of continuous variables between two groups was made by ANCOVA while adjusting for age. In comparison to the control subjects, the AD patients had a lower FMD (2.1 AE 1.7 versus 3.3 AE 2.3%, p ¼ 0.014) but a similar NMD (17.9 AE 7.2 versus 18.1 AE 6.6%, p ¼ 0.918). The NMD measured at 3 minutes after administration (NMD3) was lower in the AD patients but the difference was not statistically significant (7.6 AE 5.2 versus 10.4 AE 6.8%, p ¼ 0.070). The characteristics of the subjects are shown in Tables  1 and 2. In the AD group, FMD and NMD and NMD3 were similar between the patients with AAA and PAOD.
Time course of the brachial artery response in this study
In the 57 AD patients, the response to hyperemia reached a maximal diameter at 1.3 AE 0.6 minutes post-deflation (1 min e 42 cases, 2 min e 13 cases, 3 min e 1 case, 4 min e 1case). While in the control subjects the response to hyperemia reached a maximal diameter at at 1.1 AE 0.2 minutes (1 min e 17 cases, 2 min e 1 case). The time courses of response to NTG are shown in Figs. 1 and 2 . In the AD patients and control subjects the brachial artery reached a maximal diameter at 7.6 AE 2.2 (range 4 to 13) and 7.1 AE 0.9 (range 5 to 8) minutes post-NTG administration, The numbers in parentheses represent the percentages. *P < .05 vs control subjects. respectively. The time courses showed a sigmoid curve, a gradual increase from 0 to 2 minutes and a rapid increase from 2 to about 5 minutes, followed again by a gradual increase. In the 73 cases, only two cases (2.7%) reached a maximal diameter at 4 minutes post-NTG administration, while 66 cases (90.4%) did so at 6 minutes or later.
FMD and atherosclerotic risk factors in patients with atherosclerotic disease
According to a univariate analysis, the FMD in the 57 patients was inversely correlated with the vessel size, SBP, HOMA-IR, and it was directly and closely correlated with the maximal NMD (Fig. 3) . In a multiple stepwise regression analysis, the serum levels of insulin and brachial IMT (p < 0.1) were included in the model in addition to the above 4 parameters, and either insulin or HOMA-IR was separately included in the model because insulin correlated very closely with HOMA-IR (r ¼ 0.979, p < 0.001). The independent determinant of FMD was the NMD. No other parameter was independently associated with FMD ( Table 3 ). The squared multiple correlation coefficient adjusted for the degree of freedom (R 2 ) was 0.447 when HOMA-IR was included in the model, and 0.375 when serum levels of insulin was included.
NMD and atherosclerotic risk factors in patients with atherosclerotic disease
According to a univariate analysis, the NMD in the 55 patients was inversely correlated with the vessel size, smoking status, SBP, total cholesterol, serum levels of insulin, HOMA-IR, and it was also directly correlated with FMD. A multiple stepwise regression analysis included the brachial IMT (p < 0.1) and carotid maxIMT (p < 0.1). In a multivariate model, FMD, SBP, vessel size, carotid maxIMT, serum levels of insulin and HOMA-IR were independently associated with NMD (Table 3) . R 2 was 0.754 when HOMA-IR was included in the model and 0.714 when insulin was included.
NMD3 was associated with FMD and the vessel size, though, no other association was demonstrated between NMD3 and risk factors. Similar results were obtained when patients using hypoglycemic agents were excluded. Dilatory ratio to maximal response Fig. 2 . The time courses of the brachial artery response to NTG in control subjects. Control subjects also showed a sigmoid curve. The figure shows the curves of 16 cases because we failed to identify both of intimal interfaces at one to two points of measurements in 2 cases (Case 1 failed to identify NMD2 and NMD4. Case 2 failed NMD2). 
Discussion
The present study demonstrated a close correlation between FMD, the endothelium-dependent vasodilatory response, and NMD, the smooth muscledependent response, in patients with atherosclerotic disease. The only independent determinant of FMD was NMD on a multiple stepwise regression analysis. Independent determinants of impaired maximal NMD included a larger vessel size, higher SBP, lower FMD, increased carotid maxIMT, increased serum levels of insulin, and higher HOMA-IR. We are aware of no published reports that have described the associations between smooth muscle-dependent vasodilatation and risk factors in patients with atherosclerotic disease. Most of the studies measuring the vasodilator response induced by a single high dose of NTG at 3e4 minutes did not show any association with risk factors. We measured the vasodilator response every minute after administration, although previous reports recommended subplateau doses of NTG. 9, 18 Using this method, we detected the maximal diameter induced by a single dose of NTG. It is generally thought that NTG has a plasma half-life of 3 minutes and peak plasma concentrations occurs at 4 to 5 minutes. 19 As a result, most observers recommend measurements at 3 to 4 minutes after administration. 16 In the present study, the time courses of the vasodilatory response to NTG showed a sigmoid curve, and 90% of the subjects showed a maximal diameter after 6 minutes or later. The reason for this discrepancy was not because of dentures or of dryness of the mouth, but because pharmacodynamic or pharmacokinetic changes of NTG tend to be delayed in elderly subjects. 19 Alternatively, hypertension, insulin resistance or some other risk factors unidentified in this study may also have delayed NMD. Therefore, at least in subjects older than 54 years of age, measuring the diameter at 3 or 4 minutes post-NTG may underestimate the smooth muscle function, and observers should therefore take measurements at least 6 minutes or later when performing one point measurements.
In theory the brachial ultrasound test for endothelial function is a method measuring the relaxing effect of the smooth muscle induced by endothelium-derived endogenous nitric oxide (NO). For that reason, FMD should be considered a parameter including function of the endothelium and of smooth muscle and it would be important to evaluate smooth muscle function.
A question remains regarding whether an impaired dilator response to NTG might be due to mechanical forces limiting the artery's ability to relax or due to a decreased use of NTG inside the smooth muscle. To explain whether mechanical forces limited the vasodilatory response or not, we measured the brachial IMT, although we performed brachial ultrasound in an artery without any plaques. The brachial IMT did not significantly correlate with NMD, nor was any association observed based on a multiple regression analysis. Hence, the likely explanation for our finding is a decreased use of NTG inside the smooth muscle, i.e. smooth muscle dysfunction.
Our data demonstrated a higher FMD, a higher SBP, higher serum levels of insulin, and a higher HOMA-IR to be independently associated with an impaired NMD. The reason why FMD was involved in 20 but such a low stimulus would not evoke NO production in patients with seriously attenuated endothelial function. The mechanisms responsible for smooth muscle dysfunction remain speculative. Various mechanisms may be involved in the vascular dysfunction in complicated patients. Our speculation is that a decrease in the bioactivation of NTG by enzymes such as mtALDH (described by Chen et al.
21
) may be a possible mechanism in the development of smooth muscle dysfunction. Measuring the vasodilatory response to sodium nitroprusside, a direct stimulator of soluble guanylate cyclase, may thus help to explain whether an attenuated bioactivation of NTG is present or not.
Recently, some observers have indicated the predictive value of FMD for cardiovascular events in PAOD. 22, 23 Although NMD was not an independent predictor of event in those reports, this does not mean that NMD had no association with the clinical outcome because NMD was measured at 3 minutes after NTG administration. NMD was therefore likely underestimated.
Our study has some limitations. First, although it remains controversial regarding whether atherosclerosis is a causative factor in aneurysms, 24 we included patients with AAA in the atherosclerotic disease group because most patients with AAA exhibit risk factors for atherosclerosis, manifestations of coronary or cerebrovascular disease 1, 25 and ultrasonographic evaluation of FMD, NMD, NMD3 were similar between AAA and PAOD. Second, our sample size was limited and additional large-scale experimental studies are needed to explain the causal relationships between risk factors and an impaired vascular function. Third, although medication was discontinued for at least 14 hours before study, we cannot rule out the possibility that the long-acting effect of drugs may have beneficially influenced the FMD and NMD in the AD patients. However, long-term drug discontinuation is difficult both therapeutically and ethically.
In conclusion, in patients with AAA and PAOD, the vasodilatory response to exogenous NO was associated with FMD, SBP, the serum levels of insulin, HOMA-IR and carotid maxIMT. FMD was only associated with NMD. Regarding the value of an ultrasound test for patients with objective evidence of atherosclerotic disease, not only FMD but also NMD may be an important marker. A large-scale study evaluating the association between NMD measured with a maximal responded diameter and clinical outcome is thus called for.
